248 related articles for article (PubMed ID: 23877104)
1. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
2. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
4. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
5. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.
Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A
J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607
[TBL] [Abstract][Full Text] [Related]
6. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
7. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
8. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
9. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.
Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA
J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936
[TBL] [Abstract][Full Text] [Related]
10. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier.
Tachikawa M; Takeda Y; Tomi M; Hosoya K
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):430-6. PubMed ID: 19684012
[TBL] [Abstract][Full Text] [Related]
11. Involvement of OCTN2 and B0,+ in the transport of carnitine through an in vitro model of the blood-brain barrier.
Berezowski V; Miecz D; Marszałek M; Bröer A; Bröer S; Cecchelli R; Nałecz KA
J Neurochem; 2004 Nov; 91(4):860-72. PubMed ID: 15525340
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C restricts transport of carnitine by amino acid transporter ATB(0,+) apically localized in the blood-brain barrier.
Michalec K; Mysiorek C; Kuntz M; Bérézowski V; Szczepankiewicz AA; Wilczyński GM; Cecchelli R; Nałęcz KA
Arch Biochem Biophys; 2014 Jul; 554():28-35. PubMed ID: 24823859
[TBL] [Abstract][Full Text] [Related]
13. Human macrophage differentiation induces OCTN2-mediated L-carnitine transport through stimulation of mTOR-STAT3 axis.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Milioli M; Di Lascia M; Bernuzzi G; Dall'Asta V
J Leukoc Biol; 2017 Mar; 101(3):665-674. PubMed ID: 27733576
[TBL] [Abstract][Full Text] [Related]
14. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
16. Functional activity of L-carnitine transporters in human airway epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2016 Feb; 1858(2):210-9. PubMed ID: 26607009
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.
Inano A; Sai Y; Nikaido H; Hasimoto N; Asano M; Tsuji A; Tamai I
Biopharm Drug Dispos; 2003 Nov; 24(8):357-65. PubMed ID: 14595704
[TBL] [Abstract][Full Text] [Related]
18. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
[TBL] [Abstract][Full Text] [Related]
19. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5).
Kou L; Sun R; Ganapathy V; Yao Q; Chen R
Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
